United States Renal Data System, Annual Data Report2003, Bethesda. MD.
2.
National Kidney Foundation.K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification. Kidney disease outcome quality initiative.Am J Kidney Dis2002; 39: S1–246.
3.
JansenM.A., HartA.A., KorevaarJ.C., DekkerF.W., BoeschotenE.W., KredietR.T.. Predictor of rate of decline of residual renal function in incident dialysis patients.Kidney Int2002; 62: 1046–53.
BargmanJ.M., ThorpeK.E., ChurchillD.N.. Relative contribution of residual renal function and peritoneal clearance of adequacy of dialysis: A reanalysis of the CANUSA study.J Am Soc Nephrol2001; 12: 2158–62.
6.
CollinsA.J., HaoW., XiaH., EbbenJ.P., EversonS.F., ConstantiniE.G., MaJ.Z.. Mortality risks of peritoneal dialysis and hemodialysis.Am J Kidney Dis1999; 34: 1065–74.
7.
FentonS.S.A., SchaubelD.E., DesmeulesM., MorrisonH.I., MaoY., CoplestonP.Hemodialysis versus peritoneal dialysis: A comparison of adjusted mortality rates.Am J Kidney Dis1997; 30: 334–42.
8.
VoneshE.F., SnyderJ.J., FoleyR.N., CollinsA.J.. The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis.Kidney Int2004; 66: 2389–401.
9.
StackA.G.. Impact of timing of nephrology referral and pre-ESRD care on mortality risk among new ESRD patients in the United States.Am J Kidney Dis2003; 41: 310–8.
10.
MortierS., FaictD., SchalkwijkC.G., LameireN.H., VrieseA.S.D.. Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane.Kidney Int2004; 66: 1257–65.
11.
WilliamsJ.D., TopleyN., CraigK.J., MackenzieR.K., PischetsriederM., LageC., Passlick-DeetjenJ.. The Euro-Balance trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on peritoneal membrane.Kidney Int2004; 66: 408–18.
